Open Access Highly Accessed Research article

A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections

Peter Matthews*, Marc Alpert, Galia Rahav, Denise Rill, Edward Zito, David Gardiner, Ron Pedersen, Timothy Babinchak, Paul C McGovern and , for the Tigecycline 900 cSSSI Study Group

BMC Infectious Diseases 2012, 12:297  doi:10.1186/1471-2334-12-297

Article Metrics

3088
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 63 accesses
  • Last 365 days: 849 accesses
  • All time: 3088 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information